Literature DB >> 11697402

Tubeless percutaneous nephrolithotomy in selected patients.

B Lojanapiwat1, S Soonthornphan, S Wudhikarn.   

Abstract

BACKGROUND: Placement of the nephrostomy tube is the last step after completion of percutaneous nephrolithotomy (PCNL). We were able to demonstrate in selected patients who had undergone PCNL that the use of an externalized ureteral catheter can reduce postoperative discomfort without complications. PATIENTS AND METHODS: A total of 37 patients underwent tubeless PCNL with an externalized 6F ureteral catheter for 48 hours. Inclusion criteria were use of a single access site where the renal unit was not obstructive, no significant perforation and bleeding, and no need for a second look. The stone burden was not taken into account.
RESULTS: The procedure was performed successfully without major complications. The average length of hospitalization was 3.63 days: 25 patients stayed for 4 days, with the final day reserved for observation after removal of the catheter. The remaining 12 patients stayed only 3 days and could be discharged on the day the catheter was removed. The average intramuscular analgesic requirement was 38.57 mg of meperidine, and none of the patients needed a blood transfusion or required the emergency placement of a nephrostomy tube.
CONCLUSION: In properly selected patients, tubeless PCNL with only an externalized ureteral catheter was found to be safe and just as economical as tubeless PCNL with the same outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11697402     DOI: 10.1089/08927790152596299

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  21 in total

1.  Bilateral simultaneous tubeless percutaneous nephrolithotomy.

Authors:  Narmada P Gupta; Pawan Kumar; Monish Aron; Rajiv Goel
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

2.  Nephrostolithotomy.

Authors:  Darryl A Zuckerman; Alena Desai
Journal:  Semin Intervent Radiol       Date:  2011-12       Impact factor: 1.513

3.  Immediate postoperative morbidity in patients with indwelling double-J stent versus overnight-externalized ureteral catheter after tubeless percutaneous nephrolithotomy: a prospective, randomized study.

Authors:  Alejandro Mercado; Mario I Fernández; Pedro Recabal; Daniela Fleck; Rodrigo Ledezma; Francisco Moya; Francisco Sepúlveda; Roberto Vilches; Diego Reyes; Fernando Marchant
Journal:  Urolithiasis       Date:  2013-03-23       Impact factor: 3.436

4.  The use of the amplatz sheath in percutaneous nephrolithotomy: does amplatz sheath size matter?

Authors:  Ayhan Karaköse; Ozgu Aydogdu; Yusuf Z Atesci
Journal:  Curr Urol       Date:  2014-02-10

5.  "Ambulatory PCNL" (tubeless PCNL under regional anesthesia) -- a preliminary report of 10 cases.

Authors:  Iqbal Singh; Ashok Kumar; Praveen Kumar
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

6.  Contemporary practice of percutaneous nephrolithotomy: review of practice in a single region of the UK.

Authors:  Shalom J Srirangam; Richard Darling; Maureen Stopford; Donald Neilson
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

7.  Tubeless percutaneous nephrolithotomy: yes but when? A multicentre retrospective cohort study.

Authors:  Murat M Rifaioglu; Kadir Onem; Ibrahim Buldu; Tuna Karatag; Mustafa Okan Istanbulluoglu
Journal:  Urolithiasis       Date:  2014-01-28       Impact factor: 3.436

8.  Tubeless percutaneous nephrolithotomy.

Authors:  Madhu Sudan Agrawal; Mayank Agrawal
Journal:  Indian J Urol       Date:  2010 Jan-Mar

Review 9.  Advances in tubeless percutaneous nephrolithotomy and patient selection: an update.

Authors:  Mitra R de Cógáin; Amy E Krambeck
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

10.  Tubeless percutaneous nephrolithotomy is effective and safe in short- and long-term urinary drainage.

Authors:  Umut Gonulalan; Tufan Cicek; Okan Istanbulluoglu; Murat Kosan; Bulent Ozturk; Hakan Ozkardes
Journal:  Urolithiasis       Date:  2013-04-21       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.